Biotech Short Candidates Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Short Candidates

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (92)	10/8/2001 12:35:10 PM
From: tuck	Read Replies (2) of 897

Rick, I've only loosely followed GLIA recently. I take it you've noted LCBM's FDA approaval of a product that apparently competes. Any opinion on how competitive it is? No recent insider moves, but the chart looks toppy: siliconinvestor.com At $150 million, LCBM has almost 5x the market cap of GLIA, but despite GLIA's problems, it is behind in the marketplace now that GLIA is getting ready to restart manufacturing of ADCON, IMO. Cheers, Tuck

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next